Tumor budding is an independent prognostic factor in stage III colon cancer patients: a post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR)

Debora Basile, M. Svrcek, Jean-François Emile et al.|Annals of Oncology|2022

Cited by 44